MicroRNAs patents: The road from bench to bedsides for cancer treatment

Recent Patents on DNA and Gene Sequences

Volumn 5, Issue 2, 2011, Pages 86-91

  Wu, Wei ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Gene expression; MicroRNA; MiR drugs; MiRNome; Patents; Treatment

Indexed keywords

BIOLOGICAL MARKER; LET 7; MICRORNA; MICRORNA 106A 92; MICRORNA 122 INHIBITOR; MICRORNA 126; MICRORNA 17 92; MICRORNA 205; MICRORNA 21; MICRORNA 34A; PROTEIN INHIBITOR; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

BINDING SITE; CANCER DIAGNOSIS; CANCER THERAPY; COLON CANCER; GENE EXPRESSION; GENE SEQUENCE; HUMAN; LUNG CANCER; NONHUMAN; OVARY CANCER; PATENT; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RNA TRANSLATION; SIGNAL TRANSDUCTION; SOLID TUMOR; STOMACH CANCER;

ANTINEOPLASTIC AGENTS; GENE EXPRESSION PROFILING; HUMANS; MICRORNAS; NEOPLASMS; PATENTS AS TOPIC;

EID: 79960029337     PISSN: 18722156     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221511796392079     Document Type: Review

References (65)

1. Wilbert ML, Yeo GW. Genome-wide approaches in the study of microRNA biology. Wiley Interdiscip Rev Syst Biol Med 2010.
2. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116(2): 281-97.
3. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75(5): 843-54.
4. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001; 294(5543): 853-8.
5. Lau NC, Lim LP, Weinstein EG, Bartel DP. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001; 294(5543): 858-62.
6. Lee RC, Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001; 294(5543): 862-4.
7. Reinhart BJ, Slack FJ, Basson M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000; 403(6772): 901-6.
8. Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 2005; 6(5): 376-85.
9. Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 2010; 9(10): 775-89.
10. Li Q, Song XW, Zou J, et al. Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy. J Cell Sci 2010; 123(Pt 14): 2444-52.
11. Kawano S, Nakamachi Y. miR-124a as a key regulator of proliferation and MCP-1 secretion in synoviocytes from patients with rheumatoid arthritis. Ann Rheum Dis 2011; 70 Suppl 1: i88-91.
12. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6(11): 857-66.
13. Wu W, Sun M, Zou GM, Chen J. MicroRNA and cancer: Current status and prospective. Int J Cancer 2006.
14. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 2002; 99(24): 15524-9.
15. Takamizawa J, Konishi H, Yanagisawa K, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004; 64(11): 3753-6.
16. Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9(3): 189-98.
17. Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103(7): 2257-61.
18. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435(7043): 834-8.
19. Peltier HJ, Latham GJ. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 2008; 14(5): 844-52.
20. Volinia S, Galasso M, Costinean S, et al. Reprogramming of miRNA networks in cancer and leukemia. Genome Res 2010; 20(5): 589-99.
21. Lee Y, Yang X, Huang Y, et al. Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis. PLoS Comput Biol 2010; 6(4): e1000730.
22. Croce CM, Yanaihara N, Harris CE, et al. MicroRNA-based methods and compositions for the diagnosis,prognosis and treatment of lung cancer. EP1978986, 2008.
23. Croce CC, Schetter AJ, et al. MicroRNA-based methods and compositions for the diagnosis,prognosis and treatment of gastric cancer. WO2009108853, 2009.
24. Harris CC, Schetter AJ, et al. Inflammatory genes and microRNA-21 as biomarkers for colon cancer prognosis. WO2010036924, 2010.
25. Cohn DE, Resnick K, Alder H, et al. MicroRNA-based methods and compositions for the diagnosis and treatment of ovarian cancer. WO2010065156, 2010.
26. Nana-Sinkham SP, Hunter MG, Otterson GA. MicroRNA expression profiling and targeting in peripheral blood in lung cancer. WO2009070653, 2009.
27. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105(30): 10513-8.
28. Weber JA, Baxter DH, Zhang S, et al. The microRNA spectrum in 12 body fluids. Clin Chem 2010; 56(11): 1733-41.
29. Voortman J, Goto A, Mendiboure J, et al. MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma. Cancer Res 2010; 70(21): 8288-98.
30. Weiler J, Hunziker J, Hall J. Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? Gene Ther 2005.
31. Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007; 4(9): 721-6.
32. Xiao J, Yang B, Lin H, Lu Y, Luo X, Wang Z. Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4. J Cell Physiol 2007; 212(2): 285-92.
33. Trang P, Medina PP, Wiggins JF, et al. Regression of murine lung tumors by the let-7 microRNA. Oncogene 2009.
34. Lieberman J, Yu FY, Hu XQ. Let-7 microRNA and mimetics thereof as therapeutics for cancer. WO2008095096, 2008.
35. Trang P, Wiggins JF, Daige CL, et al. Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Mol Ther 2011.
36. Bell JC, Edge R, et al. MicroRNA medicated oncolytic targeting. WO2009111892, 2009.
37. Papagiannakopoulos T, Shapiro A, Kosik KS. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 2008; 68(19): 8164-72.
38. Asangani IA, Rasheed SA, Nikolova DA, et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008; 27(15): 2128-36.
39. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133(2): 647-58.
40. Gabriely G, Wurdinger T, Kesari S, et al. MiR-21 promotes glioma invasion by targeting MMP regulators. Mol Cell Biol 2008; 28(17): 5369-80.
41. Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 2008; 18(3): 350-9.
42. Schramedei K, Morbt N, Pfeifer G, et al. MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4. Oncogene 2011.
43. Thum T, Gross C, Fiedler J, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008; 456(7224): 980-4.
44. Gumireddy K, Young DD, Xiong X, Hogenesch JB, Huang Q, Deiters A. Small-molecule inhibitors of microrna miR-21 function. Angew Chem Int Ed Engl 2008; 47(39): 7482-4.
45. Zhang S, Chen L, Jung EJ, Calin GA. Targeting microRNAs with small molecules: from dream to reality. Clin Pharmacol Ther 2010; 87(6): 754-8.
46. Krutzfeldt J, Rajewsky N, Braich R, et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005; 438(7068): 685-9.
47. Esau C, Davis S, Murray SF, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006; 3(2): 87-98.
48. Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010; 327(5962): 198-201.
49. Bracken CP, Gregory PA, Kolesnikoff N, et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 2008; 68(19): 7846-54.
50. Chen K, Rajewsky N. Natural selection on human microRNA binding sites inferred from SNP data. Nat Genet 2006; 38(12): 1452-6.
51. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19(1): 92-105.
52. Shin C, Nam JW, Farh KK, Chiang HR, Shkumatava A, Bartel DP. Expanding the microRNA targeting code: functional sites with centered pairing. Mol Cell 2010; 38(6): 789-802.
53. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007; 318(5858): 1931-4.
54. Iwai N, Naraba H. Polymorphisms in human pre-miRNAs. Biochem Biophys Res Commun 2005; 331(4): 1439-44.
55. Landi D, Gemignani F, Naccarati A, et al. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis 2008; 29(3): 579-84.
56. Hua Z, Lv Q, Ye W, et al. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 2006; 1: e116.
57. Berezikov E, Thuemmler F, van Laake LW, et al. Diversity of microRNAs in human and chimpanzee brain. Nat Genet 2006; 38(12): 1375-7.
58. Ryu S, Joshi N, McDonnell K, et al. Discovery of novel human breast cancer MicroRNAs from deep sequencing data by analysis of Pri-MicroRNA secondary structures. PLoS One 2011; 6(2): e16403.
59. Ju JF, Go NJ. MicroRNA as biomarker in cancer. WO2008055158, 2008.
60. Civin CI. MicroRNA based methods and compositions for the treatment of cancer. WO2009091904, 2009.
61. Litman T, Echwald SM, Lindow M, et al. Novel human microRNAs associated with cancer. EP2090665, 2009.
62. Bueno MJ, Fernandez PJ, Malumbres M. Use of microRNA-203 and systems for expressing same in the manufacture of cancer drugs. WO2009112625, 2009.
63. Park JB, Park EK, Lee DH, et al. Anti-cancer composition comprising microrna molecules. WO2010008114, 2010.
64. Bae DS, Park YA. Composition containing anti-microrna for treating or preventing solid cancers. WO2010016638, 2010.
65. Wei W. MicroRNA and cancer: methods in molecular biology. Humana Press, Springer 2010.